Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Entire DC Network
In Vitro And In Vivo Comparison Of The Pathogenicity Of Four Influenza Virus Strains, Brett L. Hurst
In Vitro And In Vivo Comparison Of The Pathogenicity Of Four Influenza Virus Strains, Brett L. Hurst
All Graduate Theses and Dissertations, Spring 1920 to Summer 2023
Influenza viruses cause between 3 and 5 million cases of respiratory infection each year and are responsible for between 250 and 500 thousand deaths. Two avenues for the treatment and prevention of influenza virus infections are vaccination and antiviral chemotherapy. Prevention is largely accomplished through vaccination. While vaccines remain the preferred method for controlling the spread of influenza, antiviral treatment is important for severe infections caused by new and emerging virus strains. Occasionally new viruses emerge to which the population has no previous immunity. Such was the case when the pandemic H1N1 influenza virus appeared in 2009. When new viruses …